Iberoherb

Extract of Iberis amara, the active ingredient in Iberoherb, is a herbal liquid oral extract presented as a liquid oral extract for oral use. It is traditionally employed in herbal preparations, though specific therapeutic indications are not established.

GNH USA supplies Iberoherb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide.

Iberoherb, an herbal extract, is used in traditional herbal practice without specific regulatory‑approved indications.

- Digestive health: historically used to support normal digestion. - Liver health: traditionally employed to promote liver function. - Skin health: used in folk medicine for mild skin conditions.

Adverse reactions to Iberoherb are rarely reported in the literature.

Common Side Effects: - None reported in clinical literature. - No documented gastrointestinal complaints. - No typical allergic reactions noted.

Serious or Rare Side Effects: - None reported in published safety data. - No cases of organ toxicity have been identified. - No severe hypersensitivity reactions have been documented.

When considering Iberoherb, general herbal‑product cautions apply.

- Pregnancy and lactation: safety not established; avoid use unless advised by a healthcare professional. - Allergy: discontinue if any hypersensitivity or rash occurs. - Concomitant herbal products: monitor for additive pharmacological effects. - Underlying medical conditions: consult a physician if you have liver, kidney or cardiovascular disease. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Potential interactions with other medicines or herbs should be considered.

Major Interactions (Avoid): - None documented; however, avoid concurrent use with other potent hepatotoxic herbs without medical supervision.

Moderate Interactions (Monitor Closely): - May enhance effects of anticoagulant herbs (e.g., garlic, ginkgo) – monitor bleeding risk. - Possible additive sedative effect with CNS depressants – monitor drowsiness. - May affect metabolism of CYP450 substrates – monitor plasma levels. - May interfere with iron supplement absorption – separate dosing by at least 2 hours.